Concepedia

Mirna Lechpammer

ML

44

Publications

4.1K

Citations

26

H-Index

2002

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

University of California, Davis

Brigham and Women's Hospital

University of California Davis Medical Center

Mirna Lechpammer is an author at Harvard University specializing in medicine, pathology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2002–2023

44

Publications

44

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

Keiichi Kondo, Jeff Klco, Eijiro Nakamura et al. · Cancer Cell · 2002 · 766 citations · Full text

, , +10

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

Keiichi Kondo, William Y. Kim, Mirna Lechpammer et al. · PLoS Biology · 2003 · 596 citations · Full text

, , +14

Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

Michael B. Atkins, Meredith M. Regan, David F. McDermott et al. · Clinical Cancer Research · 2005 · 400 citations · Full text

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer

Edgard Graner, Dan Tang, Sabrina Rossi et al. · Cancer Cell · 2004 · 364 citations · Full text

, , +6

Microscopy with ultraviolet surface excitation for rapid slide-free histology

Farzad Fereidouni, Zachary T. Harmany, Miao Tian et al. · Nature Biomedical Engineering · 2017 · 261 citations · Full text

, , +4

Rows per page

1–5 of 44